跳至主要内容
临床试验/CTRI/2026/01/101857
CTRI/2026/01/101857尚未招募2/3 期

An open labelled randomized controlled trial to evaluate efficacy of Amrutadi Guggulu as an add on effect in the management of Hypothyroidism along with Thyroxine

Dr Shraddha Haraji Muley1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2026年3月2日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
52
试验地点
1

研究概览

简要总结

  1. Acharyas have described all the aspects of the disease very minutely. The management aspect of the disease is also deal with equal perfection. But we cannot find direct co-relation with a single disease from Ayurveda classics, though condition is suggestive of pathologies like Dhatvagnimandhya or Dhatvagni Vikriti, Sthaulya, Medorog or Medodosh etc. In the pathogenesis of Hypothyroidism according to the principles of Ayurveda, we find that it is basically caused due to dys-functioning of the Agni. Hypo functioning of Jatharagni, which affects Dhatvagni, eventually, brings out pathological sequence and ultimately, the diseased condition developed.

The part of the Jatharagni, which works on the Dhatu parlances and its exacerbation diminution causes respective Dhatu Vriddhi and Dhatu Kshay. 3. In today’s perspective it is difficult to treat thyroid disorders only with Ayurveda drugs. 4. Now the time has come for evaluation of add-on therapy in such type of diseases. Add-on means, that which assists especially a drug added to a prescription to hasten or increase the action of the drug. Thus, for the management of Hypothyroidism, an add -on therapy besides increasing the action of modern drugs directly on the hormones should be initiated which can reduce time and also make the treatment more cost- effective. 5. Ayurveda with great hope has a golden treasure of natural ways of healing and a vast pharmacopoeia of Rasayana drugs that can provide such an effective add-on therapy. Keeping wellbeing of humanity as chief concern, if the best of two pathy are combined, without making much choose about the purity of science, an effective and successful.Once in mind this study has been planned to provide better, safer and faster relief to patients suffering from Hypothyroidism and for this purpose this ‘Amrutadi Guggulu’ has been used.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Patients between the ages of 19 years to 50 years with irrespective sex, cast, religions.
  • Thyroid stimulating hormone (TSH) level more than 4.25 3) Patient currently on Tab.
  • Thyroxine 25 mcg to 100 mcg 4) Chronicity of hypothyroidism below 5 years.
  • Patients suffering from Hypothyroidism.

排除标准

  • Patients having any other major complicated systematic diseases like cardiac disease, diabetes mellitus.
  • Drugs (Amiodarone, Lithium) induce Hypothyroidism.
  • Pregnancy and lactating mother.
  • Hypothyroidism caused due to the administration of chemotherapy, radiotherapy and post thyroidectomy.

研究者

发起方
Dr Shraddha Haraji Muley
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR YOGESH TUKARAM KOTANGALE

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

研究点 (1)

Loading locations...

相似试验